Company / Tangible Book Value per Share
NeoGenomics Laboratories, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.44
FY2025
5-year range
$2.44 / $4.84
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
#106 of 158
Health Care
What the data says
At $2.44, NeoGenomics Laboratories, Inc.'s tangible book value per share ranks #106 of 158 in the Health Care sector. Tangible Book Value per Share has declined for 4 consecutive years, from $4.84 in FY2021 to $2.44 in FY2025.
Based on SEC 10-K filings.
2.44 in FY2025 with a 5-year CAGR of -10.8%.
Declined from $3.34 to $2.44 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -14.0%
- 5-Year CAGR
- -10.8%
- 10-Year CAGR
- -
Sector benchmark
#106 of 158 in Health CareTop 67% of 158This company $2.44 Sector average $18.47
▼
-86.8% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s tangible book value per share has declined for 4 consecutive years.
- In FY2025, tangible book value per share decreased 18.7% year-over-year.
- Ranks #106 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.44 | -18.7% |
| FY2024 | $3.00 | -10.2% |
| FY2023 | $3.34 | -12.8% |
| FY2022 | $3.83 | -21.0% |
| FY2021 | $4.84 | +12.1% |
| FY2020 | $4.32 | +45.0% |
| FY2019 | $2.98 | +122.7% |
| FY2018 | $1.34 | +321.6% |
| FY2017 | $0.32 | +57.3% |
| FY2016 | $0.20 | -80.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026